- US-listed companies
- IceCure Medical Ltd.
- Income statement
IceCure Medical Ltd. (ICCM) Income statement
Market cap
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 4 | 3 | 3 | 3 | 3 |
| Revenue growth (%) | - | ||||
| Cost of revenue | 2 | 2 | 2 | 2 | 2 |
| Gross profit | 2 | 1 | 1 | 1 | 1 |
| Gross margin (%) | |||||
| Research & development | 6 | 9 | 8 | 7 | 7 |
| Selling, general & administrative | 0 | 1 | - | - | - |
| Operating margin (%) | |||||
| Operating income | 10 | -17 | -16 | -16 | -15 |
| Net income | -10 | -17 | -15 | -15 | -15 |
| Net income margin (%) | |||||
| Earnings per share | 0.35 | 0.46 | 0.32 | 0.3 | 0.24 |
| Diluted EPS | 0.35 | 0.46 | 0.32 | 0.3 | 0.24 |